Valvular & structural heart disease

Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling: The TRILUMINATE Pivotal Imaging Substudy

J Am Coll CardiolPublished Secondary analysis of the TRILUMINATE Pivotal randomised trial

Authors' conclusion

Advanced imaging from the TRILUMINATE Pivotal imaging substudy demonstrated that TriClip effectively reduced TR. Significant cardiac remodeling was observed at 30 days and sustained at 1 year. With TriClip, the extent of cardiac remodeling was associated with the degree of TR reduction.

Study context

Population
Symptomatic patients with severe tricuspid regurgitation (TR)
Participants
69 patients
Comparison
TriClip vs medical therapy
  • TriClipn = 31
  • Controln = 38reference
Primary endpoint
Longitudinal changes in right heart remodeling by CMR and 4D-CT
Follow-up
30 days and 1 year
Methodological detailsprospective imaging substudy, 10 sites, imaging core lab
  • Prospective imaging substudy
  • 10 sites
  • Imaging core lab

Primary result

As reported in the abstract

Right heart remodeling · 30 days
TR volume significantly decreased with TriClip (70% reduction)
P < 0.0001
Association between changes in TR volume and RV end-diastolic volume
r = 0.90; P < 0.0001
RV end-diastolic volume reduction with TriClip (12% reduction), sustained through 1 year
P < 0.001
Tricuspid annular area reduction with TriClip (11% reduction), sustained through 1 year
P < 0.0001

Original publication

Advanced Imaging Assessment of the Impact of Tricuspid Regurgitation on Cardiac Remodeling: The TRILUMINATE Pivotal Imaging Substudy. J Am Coll Cardiol. Published 20 November 2024. doi:10.1016/j.jacc.2024.09.009

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.